Nitric oxide and virus infection
暂无分享,去创建一个
[1] H. Maeda,et al. Protective effect of S-nitrosylated alpha(1)-protease inhibitor on hepatic ischemia-reperfusion injury. , 2000, The Journal of pharmacology and experimental therapeutics.
[2] T. Akaike,et al. Tyrosine Nitration by Peroxynitrite Formed from Nitric Oxide and Superoxide Generated by Xanthine Oxidase* , 2000, The Journal of Biological Chemistry.
[3] J. Beckman,et al. Superoxide Reacts with Nitric Oxide to Nitrate Tyrosine at Physiological pH via Peroxynitrite* , 2000, The Journal of Biological Chemistry.
[4] Gregory F. Wu,et al. Coronavirus-Induced Demyelination Occurs in the Absence of Inducible Nitric Oxide Synthase , 2000, Journal of Virology.
[5] H. Maeda,et al. Helicobacter pylori Urease Suppresses Bactericidal Activity of Peroxynitrite via Carbon Dioxide Production , 2000, Infection and Immunity.
[6] G. Dougan,et al. Antimicrobial Actions of the Nadph Phagocyte Oxidase and Inducible Nitric Oxide Synthase in Experimental Salmonellosis. II. Effects on Microbial Proliferation and Host Survival in Vivo , 2000, The Journal of experimental medicine.
[7] F. Fang,et al. Antimicrobial Actions of the Nadph Phagocyte Oxidase and Inducible Nitric Oxide Synthase in Experimental Salmonellosis. I. Effects on Microbial Killing by Activated Peritoneal Macrophages in Vitro , 2000, The Journal of experimental medicine.
[8] H. Maeda,et al. Viral mutation accelerated by nitric oxide production during infection in vivo. , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] H. Ischiropoulos,et al. Cooperation between Reactive Oxygen and Nitrogen Intermediates in Killing of Rhodococcus equi by Activated Macrophages , 2000, Infection and Immunity.
[10] C. Nathan,et al. Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria. , 2000, Current opinion in microbiology.
[11] T. Akaike. Mechanisms of biological S-nitrosation and its measurement , 2000, Free radical research.
[12] R. Zinkernagel,et al. IL-4 and IL-10 Antagonize IL-12-Mediated Protection Against Acute Vaccinia Virus Infection with a Limited Role of IFN-γ and Nitric Oxide Synthetase 21 , 2000, The Journal of Immunology.
[13] H. Maeda,et al. Pathophysiological Effects of High-Output Production of Nitric Oxide , 2000 .
[14] J S Beckman,et al. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. , 1999, Science.
[15] A. Álvarez,et al. Nitric oxide induces tyrosine nitration and release of cytochrome c preceding an increase of mitochondrial transmembrane potential in macrophages , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] R. Hruban,et al. Inducible nitric oxide synthase protection against coxsackievirus pancreatitis. , 1999, Journal of immunology.
[17] A. Thomsen,et al. Inducible nitric-oxide synthase plays a minimal role in lymphocytic choriomeningitis virus-induced, T cell-mediated protective immunity and immunopathology. , 1999, The Journal of general virology.
[18] P. McMinn,et al. The Severity of Murray Valley Encephalitis in Mice Is Linked to Neutrophil Infiltration and Inducible Nitric Oxide Synthase Activity in the Central Nervous System , 1999, Journal of Virology.
[19] M. Hollenberg,et al. Prevention of Encephalomyocarditis Virus-Induced Diabetes in Mice by Inhibition of the Tyrosine Kinase Signalling Pathway and Subsequent Suppression of Nitric Oxide Production in Macrophages , 1999, Journal of Virology.
[20] A. Matsumori,et al. Treatment of experimental viral myocarditis with interleukin-10. , 1999, Circulation.
[21] F. Belardelli,et al. Inhibitory Activity of Constitutive Nitric Oxide on the Expression of Alpha/Beta Interferon Genes in Murine Peritoneal Macrophages , 1999, Journal of Virology.
[22] G. Barbarini,et al. Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA). , 1999, Circulation.
[23] T. Kemper,et al. Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex , 1999, Annals of neurology.
[24] H. Tsutsumi,et al. Respiratory syncytial virus infection of human respiratory epithelial cells enhances inducible nitric oxide synthase gene expression , 1999, Journal of leukocyte biology.
[25] T. Sairenji,et al. Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines. , 1999, Virology.
[26] M. Zeng,et al. Fas-induced caspase denitrosylation. , 1999, Science.
[27] H. Maeda,et al. Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats. , 1999, Virology.
[28] K. Clouse,et al. Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome. , 1999, Blood.
[29] C. Lowenstein,et al. An Antiviral Mechanism of Nitric Oxide , 1999, Immunity.
[30] T. Dawson,et al. Mechanisms and Structural Determinants of HIV-1 Coat Protein, gp41-Induced Neurotoxicity , 1999, The Journal of Neuroscience.
[31] D. Stuehr. Mammalian nitric oxide synthases. , 1999, Biochimica et biophysica acta.
[32] M. Dinauer,et al. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. , 1999, Immunity.
[33] H. Kolb,et al. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? , 1998, Immunology today.
[34] G. Karupiah,et al. Rapid Interferon γ–dependent Clearance of Influenza A Virus and Protection from Consolidating Pneumonitis in Nitric Oxide Synthase 2–deficient Mice , 1998, The Journal of experimental medicine.
[35] M. Beck,et al. Glutathione peroxidase protects mice from viral‐induced myocarditis , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] G. Karupiah,et al. Identification of Nitric Oxide Synthase 2 as an Innate Resistance Locus against Ectromelia Virus Infection , 1998, Journal of Virology.
[37] G. Wogan,et al. Mutagenesis associated with nitric oxide production in macrophages. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[38] F. Liew,et al. Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. , 1998, The Journal of general virology.
[39] E. Lara-Pezzi,et al. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. , 1998, The Journal of clinical investigation.
[40] C. Lowenstein,et al. The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[41] T. Akaike,et al. Free Radicals in Viral Pathogenesis: Molecular Mechanisms Involving Superoxide and NO , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[42] C. Nathan,et al. Perspectives Series : Nitric Oxide and Nitric Oxide Synthases Inducible Nitric Oxide Synthase : What Difference Does It Make ? , 2013 .
[43] H. Esumi,et al. Nitric oxide inhibits CPP32-like activity under redox regulation. , 1997, Biochemical and Biophysical Research Communications - BBRC.
[44] H. Maeda,et al. Induction of nitric oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against Salmonella typhimurium infection in mice , 1997, Infection and immunity.
[45] H. Maeda,et al. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. , 1997, Archives of biochemistry and biophysics.
[46] A. Sher,et al. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection. , 1997, Journal of immunology.
[47] J. Mudgett,et al. Identification of nitric oxide synthase as a protective locus against tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[48] L. Kobzik,et al. Suppression of Herpes Simplex Virus Type 1 (HSV-1)–induced Pneumonia in Mice by Inhibition of Inducible Nitric Oxide Synthase (iNOS, NOS2) , 1997, The Journal of experimental medicine.
[49] X. Mo,et al. The cytotoxic T-lymphocyte response to Sendai virus is unimpaired in the absence of gamma interferon , 1997, Journal of virology.
[50] X. Mo,et al. Modification of the Sendai virus-specific antibody and CD8+ T-cell responses in mice homozygous for disruption of the interleukin-4 gene , 1997, Journal of virology.
[51] M. Takiguchi,et al. Coinduction of Nitric-oxide Synthase and Arginase I in Cultured Rat Peritoneal Macrophages and Rat Tissues in Vivo by Lipopolysaccharide* , 1997, The Journal of Biological Chemistry.
[52] H. Lander. An essential role for free radicals and derived species in signal transduction , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[53] J S Beckman,et al. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.
[54] M. Takiguchi,et al. Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage‐like cell line , 1996, FEBS letters.
[55] B. Freeman,et al. Nitric oxide regulation of tissue free radical injury. , 1996, Chemical research in toxicology.
[56] M. Eibl,et al. Nitric oxide and viral infection: NO antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo. , 1996, Virology.
[57] K. Hirata,et al. Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3. , 1996, Biochemical and biophysical research communications.
[58] H. Maeda,et al. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[59] G. Wogan,et al. Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. , 1996, Mutation research.
[60] H. Masumoto,et al. The reaction of ebselen with peroxynitrite. , 1996, Chemical research in toxicology.
[61] Rolf M. Zinkernagel,et al. Immunology Taught by Viruses , 1996, Science.
[62] M. Eibl,et al. SHORT COMMUNICATION Nitric Oxide and Viral Infection: No Antiviral Activity against a Flavivirus in Vitro, and Evidence for Contribution to Pathogenesis in Experimental Infection in Vivo , 1996 .
[63] H. Ohshima,et al. Formation of 8‐nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination , 1995, FEBS letters.
[64] S. James. Role of nitric oxide in parasitic infections. , 1995, Microbiological reviews.
[65] H. Ohshima,et al. Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. , 1995, Carcinogenesis.
[66] F. Fang,et al. Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[67] I. Charles,et al. Altered immune responses in mice lacking inducible nitric oxide synthase , 1995, Nature.
[68] M. Beck,et al. Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates , 1995, Nature Medicine.
[69] A. Nomoto,et al. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor , 1995, The Journal of experimental medicine.
[70] S. Lipton,et al. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV- associated neurological disease , 1995, The Journal of experimental medicine.
[71] M. Modolell,et al. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. , 1995, Biochemical and biophysical research communications.
[72] M. Schaefer,et al. Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain. , 1995, Journal of neurovirology.
[73] J. Stamler,et al. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation , 1994, Cell.
[74] M. Graham,et al. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection , 1994, The Journal of experimental medicine.
[75] A. Taylor-Robinson,et al. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells , 1994, European journal of immunology.
[76] Y. Vodovotz,et al. Mechanism of suppression of nitric oxide synthase expression by interleukin‐4 in primary mouse macrophages , 1994, Journal of leukocyte biology.
[77] J. Stamler,et al. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[78] M. Graham,et al. Response to influenza infection in mice with a targeted disruption in the interferon gamma gene , 1993, The Journal of experimental medicine.
[79] Z. Fu,et al. Severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease correlate with the induction of nitric oxide synthase , 1993, Journal of virology.
[80] G. Karupiah,et al. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. , 1993, Science.
[81] H. Maeda,et al. Pronounced enhancement of .NO-dependent antimicrobial action by an .NO-oxidizing agent, imidazolineoxyl N-oxide , 1993, Infection and immunity.
[82] Y. Vodovotz,et al. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta , 1993, The Journal of experimental medicine.
[83] K. Croen,et al. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. , 1993, The Journal of clinical investigation.
[84] H. Maeda,et al. Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis , 1993, Infection and immunity.
[85] A. Ramsay,et al. A case for cytokines as effector molecules in the resolution of virus infection. , 1993, Immunology today.
[86] L. Rorke,et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[87] P. López-Jaramillo,et al. The L-arginine: nitric oxide pathway. , 1993, Current opinion in nephrology and hypertension.
[88] J. Stamler,et al. Biochemistry of nitric oxide and its redox-activated forms. , 1992, Science.
[89] S. Moncada,et al. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. , 1992, Biochemical and biophysical research communications.
[90] T. Akaike,et al. Oxygen Free Radicals as Pathogenic Molecules in Viral Diseases , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[91] R. Jaenisch,et al. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells , 1991, The Journal of experimental medicine.
[92] C. Nathan,et al. Role of nitric oxide synthesis in macrophage antimicrobial activity. , 1991, Current opinion in immunology.
[93] H. Maeda,et al. Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. , 1990, The Journal of clinical investigation.
[94] B. Freeman,et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[95] S. Jonjić,et al. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.
[96] J. Perfect,et al. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. , 1988, The Journal of clinical investigation.
[97] S. Weitzman,et al. Mutation caused by human phagocytes. , 1981, Science.
[98] J. A. Badwey,et al. Active oxygen species and the functions of phagocytic leukocytes. , 1980, Annual review of biochemistry.
[99] J. Bennink,et al. Different rules govern help for cytotoxic T cells and B cells , 1978, Nature.